ClinicalTrials.Veeva

Menu

Astigmatism Post-trabeculectomy

U

Universitaire Ziekenhuizen KU Leuven

Status

Completed

Conditions

Glaucoma

Treatments

Procedure: trabeculectomy

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this project:

  1. Confirming the modification in corneal astigmatism after trabeculectomy with MMC and intracameral administration of bevacizumab.
  2. Medium-term follow up (6 months) of the induced corneal astigmatism.
  3. Investigating correlations between postoperative astigmatism, particularly with the postoperative IOP.

Enrollment

52 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Primary open angle glaucoma
  • Normal tension glaucoma
  • Pseudoexfoliation glaucoma
  • Pigment dispersion glaucoma

Exclusion criteria

  • Patients who refuse to sign the informed consent.
  • Patients with primary angle closure glaucoma (PACG).
  • Patients younger than 18 years old.
  • Other ocular diseases besides glaucoma.
  • Significant corneal opacities.
  • Refractive error more than + or -6.00 diopters.
  • Visual acuity less than 0.05
  • Previous intra-ocular surgery (except cataract surgery more than six months preceding the trabeculectomy).
  • Laser treatment for glaucoma within 6 months of the surgery.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems